Compare Ticagrelor vs Clopidogrel on the Reduction of Arterial Stiffness and Wave Reflectionsin Patients With CAD.
A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 120 participants.
Also called NCT02071212
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 120 participants
- Sponsor
- Registry
-
NCT02071212
-
- Other papers using this trial's data
- Effect of Ticagrelor Versus Clopidogrel on Aortic Stiffness in Patients With Coronary Artery Disease
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Greece
- Registry status
- Completed
Technical summary
Registry record NCT02071212. Randomized; single masking; primary purpose treatment. Start 2014-02 (registry gives no type); primary completion 2018-06 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Compare Ticagrelor vs Clopidogrel on the Reduction of Arterial Stiffness and Wave Reflectionsin Patients With CAD.
- Acronym
- NOVELTY
- Condition
- Coronary Artery Disease
- Intervention (Drug)
- Ticagrelor
- Lead sponsor
- Hellenic Cardiovascular Research Society
- Collaborator
- AstraZeneca
Record details
- Record id
cardio:ct-nct02071212- Content hash
6f65d1a757d2c8d2860be2bd3b80f6b5f2667725eaa5f7f94a074417d2d92889